Press release

Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit.

articleIllumina, Inc.August 6, 20203/company/illumina-inc/news/illumina-announces-the-novaseqtm-6000-v15-reagent-kit-unlocking-deeper-discoveries
Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

About this update from Illumina, Inc.

[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nIllumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit. The new NovaSeq 6000 v1.5 Reagent Kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes with the introduction of the $600 genome. By delivering on key customer requests, and a more attractive price per sample for all applications, the new kits bring data-rich applications—such as single cell genomics, whole genome sequencing, and liquid biopsy—within closer reach to help researchers unlock the full story of genetic variation and answer their biggest biological questions.\n\n\n“In order to explore biology at higher resolution, we rely on technologies that enable us to dive deeper into previously unrecognized cell types with single cell and spatial applications,” said Edwin Hauw, Vice President of Marketing at 10x Genomics. “Together with Illumina's technologies, we are able to simplify and amplify our workflows to capture new insights into the inner workings of biology.”\n\n\n“As a scientist, I consistently push the limits of my research and drive innovation with each new discovery,” said Dr. Christopher Mason. “Illumina’s pioneering technology and leading-edge advancements help unlock new applications in an accessible way, giving researchers the ability to concentrate on life-impacting science, for everything from COVID-19 and infectious disease, to cancer and epigenetics.”\n\n\nCoupled with the new NovaSeq 6000 v1.5 Reagent Kit, NovaSeq 6000 can accelerate scientific breakthroughs with tremendous flexibility, accuracy and scale—delivering unique, industry-changing capabilities to drive discovery through deep sequencing, access to data-intensive next generation sequencing applications, and sequencing of large sample cohorts—now more affordable than ever.\n\n\nIn addition to the improved per sample sequencing cost, the NovaSeq 6000 v1.5 Reagent Kits have been enhanced to include the following key features:\n\n\n\nImproved Quality Specification Score – Manufacturing enhancements alongside robust formulations provides a new level of confidence and quality with average Q30 scores of ≥ 85 percent, for read lengths up to 2x150bp.\n\n\nFully Supported Unique Molecular Identifiers (UMIs) – Additional cycles per kit enable customers to adopt U...

More updates from Illumina, Inc.